Vimarsana
Biggest News Aggregation in the World

Page 8 - Diagnostic Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostic Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostic Testing Today - Breaking & Trending Today

Pleural Disease Market to Reach $6.09 billion by 2030: - Vimarsana News

Pleural Disease Market to Reach $6.09 billion by 2030:

Pleural disease encompasses various conditions affecting the pleura, the thin membrane surrounding the lungs. Pleurisy involves inflammation of the pleura,...

Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research - Vimarsana News

Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research

Rise in incidence of the Lyme disease and growth in awareness about diagnostic tests are key Lyme disease diagnostics market drivers. The number of people affected with the Lyme disease is rising, particularly in regions with high prevalence of ticks.Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023 and is expected to expand at a CAGR of 3.8% until 203

Source: yahoo.com
ASCO 2023: Health Equity - Vimarsana News

ASCO 2023: Health Equity

Coverage of sessions on disparities in access to clinical trials and cancer screening, as well as relationships each to outcomes. A joint session presented by ASCO and the European Society for Medical Oncology (ESMO) highlighted progress and lingering gaps in lung and colorectal screening.

Source: ajmc.com
Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript - Vimarsana News

Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript

Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript August 7, 2023 Biodesix, Inc. misses on earnings expectations. Reported EPS is $-0.17013 EPS, expectations were $0.21. Operator: Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After […]

Source: yahoo.com
United States Women Health Laboratory Testing Market Analysis 2023-2028 - Cancer Prevalence Among Women Creates New Opportunities - Vimarsana News

United States Women Health Laboratory Testing Market Analysis 2023-2028 - Cancer Prevalence Among Women Creates New Opportunities

/PRNewswire/ -- The "United States Women Health Laboratory Testing Market by Hereditary Cancer, Reproductive Health and Infectious Diseases, Prenatal Screening...